CSIMarket Company Name, Ticker, Customers, else..
 

Simulations Plus Inc   (NASDAQ: SLP)

Simulations Plus Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

SLP Sales vs. its Competitors Q3 2026


Comparing the current results to its competitors, Simulations Plus Inc reported Revenue increase in the 3 quarter 2026 by 9.29 % year on year, while most of its competitors have experienced contraction in revenues by -7.58 %, achieved in the same quarter.

• List of SLP Competitors

With a net margin of 16.33 % Simulations Plus Inc achieved higher profitability than its competitors.

• More on SLP Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison

Simulations Plus Inc achieved net profit of $3.58 millions compared to a net loss of $-67.32 millions recorded in the same quarter a year ago.

<<  SLP Stock Performance Comparisons





  

Overall company Market Share Q3 2026
With revenue growth of 9.29 % within Overall company, Simulations Plus Inc achieved improvement in market share, within Overall company to approximately 19.01 %.
<<  More on SLP Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Simulations Plus Inc




Certara Inc
Share Performance



+6.15%
30 Days
Certara Inc
Profile

is a global leader in biosimulation based

More about Certara Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,278.074 mill. $ 408.450 mill. $ -69.000 mill.


Icon Plc
Share Performance



+1.91%
30 Days
Icon Plc
Profile

Icon Plc is a leading provider of clinical research services, specializing in the design and management of clinical trials for pharmaceutical and biotechnology companies. Their business model focuses on offering a comprehensive range of services, including study design, data management, regulatory support, and statistical analysis, to support the development of new drugs and medical devices. Icon Plc's success lies in its ability to provide customized solutions to its clients, efficiently navigate the regulatory landscape, and consistently deliver high-quality and timely results.

More about Icon Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 12,621.830 mill. $ 14,390.163 mill. $ 229.339 mill.


Schrodinger Inc
Share Performance



+7.24%
Over The Past 5 Days
Schrodinger Inc
Profile

Schrodinger Inc is a computational drug discovery company that utilizes physics-based solutions to accelerate the discovery and development of new drugs. Their business model involves providing software and services to pharmaceutical and biotechnology companies, enabling them to optimize and streamline their drug discovery processes. By leveraging their unique expertise in computational chemistry and molecular modeling, Schrodinger aims to empower their clients in the pursuit of efficient and effective drug development.

More about Schrodinger Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,544.893 mill. $ 254.905 mill. $ -103.483 mill.

Sources: Simulations Plus Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Simulations Plus Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.